0001193125-24-136307.txt : 20240510 0001193125-24-136307.hdr.sgml : 20240510 20240510173112 ACCESSION NUMBER: 0001193125-24-136307 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20240506 ITEM INFORMATION: Material Impairments FILED AS OF DATE: 20240510 DATE AS OF CHANGE: 20240510 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MEDICAL PROPERTIES TRUST INC CENTRAL INDEX KEY: 0001287865 STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798] ORGANIZATION NAME: 05 Real Estate & Construction IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-32559 FILM NUMBER: 24936164 BUSINESS ADDRESS: STREET 1: 1000 URBAN CENTER DRIVE STREET 2: SUITE 501 CITY: BIRMINGHAM STATE: AL ZIP: 35242 BUSINESS PHONE: 205-969-3755 MAIL ADDRESS: STREET 1: 1000 URBAN CENTER DRIVE STREET 2: SUITE 501 CITY: BIRMINGHAM STATE: AL ZIP: 35242 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MPT Operating Partnership, L.P. CENTRAL INDEX KEY: 0001524607 STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798] ORGANIZATION NAME: 05 Real Estate & Construction IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-177186 FILM NUMBER: 24936165 BUSINESS ADDRESS: STREET 1: MEDICAL PROPERTIES TRUST, INC. STREET 2: 1000 URBAN CENTER DRIVE, SUITE 501 CITY: BIRMINGHAM STATE: AL ZIP: 35242 BUSINESS PHONE: 205-969-3755 MAIL ADDRESS: STREET 1: MEDICAL PROPERTIES TRUST, INC. STREET 2: 1000 URBAN CENTER DRIVE, SUITE 501 CITY: BIRMINGHAM STATE: AL ZIP: 35242 8-K 1 d803751d8k.htm 8-K 8-K
MEDICAL PROPERTIES TRUST INCfalse00012878650001524607ALAL 0001287865 2024-05-06 2024-05-06 0001287865 mpw:MptOperatingPartnershipLpMember 2024-05-06 2024-05-06
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
 
FORM
8-K
 
 
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): May 6, 2024
 
 
MEDICAL PROPERTIES TRUST, INC.
MPT OPERATING PARTNERSHIP, L.P.
(Exact Name of Registrant as Specified in Charter)
 
 
Commission File Number
001-32559
 
Maryland
  
20-0191742
Delaware
  
20-0242069
(State or other jurisdiction of
incorporation or organization)
  
(I.R.S. Employer
Identification No.)
 
1000 Urban Center Drive, Suite 501
Birmingham,
AL
  
35242
(Address of principal executive offices)
  
(Zip Code)
Registrant’s telephone number, including area code
(205)
969-3755
 
 
Check the appropriate box below if the Form
8-K
filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:
 
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
☐
Soliciting material pursuant to Rule
14a-12
under the Exchange Act (17 CFR
240.14a-12)
 
☐
Pre-commencement
communications pursuant to Rule
14d-2(b)
under the Exchange Act (17 CFR
240.14d-2(b))
 
☐
Pre-commencement
communications pursuant to Rule
13e-4(c)
under the Exchange Act (17 CFR
240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
  
Trading
Symbol
  
Name of each exchange
on which registered
Common Stock, par value $0.001 per share, of Medical Properties Trust, Inc.   MPW   The New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule
12b-2
of the Securities Exchange Act of 1934
(§240.12b-2
of this chapter).
Emerging growth company ☐     
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
 
 
Item 2.06.
Material Impairments
As previously disclosed in the Current Report on Form
8-K
furnished by Medical Properties Trust, Inc. (together with its affiliates, the “Company”) with the SEC on May 9, 2024, Steward Health Care System LLC (“Steward”) filed a voluntary petition for relief, under Chapter 11 of the U.S. Bankruptcy Code in the U.S. Bankruptcy Court for the Southern District of Texas on May 6, 2024. At March 31, 2024, affiliates of Steward lease 28 healthcare facilities from the Company under a master lease totaling approximately $2.4 billion, along with eight properties pursuant to a separate master lease agreement with an unconsolidated joint venture in which the Company’s investment is approximately $406 million. In addition to the master leases, the Company holds a working capital and other secured loans to Steward totaling approximately $346 million, in addition to a $362 million loan to affiliates of Steward. The Company also holds a 9.9% equity investment in Steward.
As the Company previously reported in its Annual Report on Form
10-K
for the year ended December 31, 2023, the Company moved to the cash basis of accounting for all its leases and loans with Steward effective December 31, 2023, due to the ongoing operational and liquidity challenges faced by Steward. This resulted in the reserving of all unpaid rent and interest receivables at December 31, 2023 and the reversal of previously recognized straight-line rent receivables. In addition, the Company recorded impairment charges on certain real estate assets and on its 9.9% equity interest in Steward. In total, the Company recorded approximately $700 million of impairment and other charges.
Further to Steward’s voluntary petition for relief under the Bankruptcy Code, the Company has concluded the investments in Steward have been further materially impaired and has recorded approximately $470 million of additional impairment charges in the quarter ended March 31, 2024 that fully reserves for the remaining value of our 9.9% equity interest in Steward and the $362 million loan due from affiliates of Steward, along with an accrual for property taxes and obligations not paid by Steward under its master leases. Based on an updated fair value analysis of the collateral underlying the Company’s $346 million of
non-real
estate loans to Steward, the Company believes these investments are fully recoverable at this time.
At this time, the Company is unable to estimate the amount of cash expenditures that the Company may incur in pursuing recovery of its Steward investments and no assurances can be given that the Company will not have any additional impairments in future periods.
Safe Harbor Disclosure
This Current Report on Form
8-K
includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements can generally be identified by the use of forward-looking words such as “may”, “will”, “would”, “could”, “expect”, “intend”, “plan”, “estimate”, “target”, “anticipate”, “believe”, “objectives”, “outlook”, “guidance” or other similar words, and include statements regarding our strategies, objectives, future expansion and development activities, asset sales and other liquidity transactions, expected returns on investments and expected financial performance. Forward-looking statements involve known and unknown risks and uncertainties that may cause our actual results or future events to differ materially from those expressed in or underlying such forward-looking statements, including, but not limited to: (i) the risk that the Company is not able to recover deferred rent or its other investments in Steward at full value, within a reasonable time period or at all; (ii) the risks and uncertainties associated with the Company’s ability to pursue legal remedies in the Steward bankruptcy, including any restructuring of its various investments in Steward, and (iii) such other risks and uncertainties detailed from time to time in the Company’s filings with the Securities and Exchange Commission. The Company disclaims any responsibility to update such forward-looking statements, which speak only as of the date on which they were made.
 
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunder duly authorized.
 
MEDICAL PROPERTIES TRUST, INC.
By:  
/s/ R. Steven Hamner
Name:   R. Steven Hamner
Title:   Executive Vice President and Chief Financial Officer
MPT OPERATING PARTNERSHIP, L.P.
By:  
/s/ R. Steven Hamner
Name:   R. Steven Hamner
Title:  
Executive Vice President and Chief Financial
Officer of the sole member of the general
partner of MPT Operating Partnership, L.P.
Date: May 10, 2024
 
3
EX-101.SCH 2 mpw-20240506.xsd XBRL TAXONOMY EXTENSION SCHEMA 1001 - Document - Cover Page link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 3 mpw-20240506_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 4 mpw-20240506_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 5 mpw-20240506_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 6 mpw-20240506_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 8 R1.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Cover Page
May 06, 2024
Document Information [Line Items]  
Entity Registrant Name MEDICAL PROPERTIES TRUST INC
Amendment Flag false
Entity Central Index Key 0001287865
Document Type 8-K
Document Period End Date May 06, 2024
Entity File Number 001-32559
Entity Incorporation State Country Code MD
Entity Tax Identification Number 20-0191742
Entity Address, Address Line One 1000 Urban Center Drive
Entity Address, Address Line Two Suite 501
Entity Address, City or Town Birmingham
Entity Address, State or Province AL
Entity Address, Postal Zip Code 35242
City Area Code 205
Local Phone Number 969-3755
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Common Stock, par value $0.001 per share, of Medical Properties Trust, Inc.
Trading Symbol MPW
Security Exchange Name NYSE
Entity Emerging Growth Company false
MPT Operating Partnership LP [Member]  
Document Information [Line Items]  
Entity Registrant Name MPT OPERATING PARTNERSHIP, L.P.
Entity Central Index Key 0001524607
Entity Incorporation State Country Code DE
Entity Tax Identification Number 20-0242069
Entity Address, Address Line One 1000 Urban Center Drive
Entity Address, Address Line Two Suite 501
Entity Address, City or Town Birmingham
Entity Address, State or Province AL
Entity Address, Postal Zip Code 35242
City Area Code 205
Local Phone Number 969-3755
Entity Emerging Growth Company false
EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( .2+JE@'04UB@0 +$ 0 9&]C4')O<',O87!P+GAM M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGDK7A.YNJQ<&4GPZ4A!0W_J=0U[R;UEA_6\#MI7E!+ P04 M " #DBZI8,#8VYNX K @ $0 &1O8U!R;W!S+V-O&ULS9+! M2L0P$(9?17)O)VG50^CFHGA2$%Q0O(5D=C?8-"$9:??M;>-N%]$'\)B9/]]\ M ].9*$U(^)Q"Q$0.\]7D^R%+$S?L0!0E0#8']#K7X2&\UOP2-IJTK J[@2F>JLD2:AII!.>&M6?/Q,?8%9 ]BCQX$RB%H 4\O$ M>)SZ#BZ !4:8?/XNH%V)I?HGMG2 G9)3=FMJ',=Z;$MNWD' V]/C2UFW3M^^+ZP^\B[(-U._>/ MC<^"JH-?=Z&^ %!+ P04 " #DBZI8F5R<(Q & "<)P $P 'AL+W1H M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X M8-DOV]:[MR_>X%#BVR]*+ M41B1%G\@M MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7 MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V< M/!T3$LV4"P9!AI@S M&L%&KQMUAVC2/'K^!?F<-0HACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0' MHYI9";V$5FJ?JH,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RSTS0LS0[=R2^JVE+ZU)CA* M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D* MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-# MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P MOFH]M!5.S_Y9KF4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2 MD 83 >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+ M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5 M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0 ( M .2+JEB0O?;\BP4 "@: 8 >&PO=V]R:W-H965T&UL MM5EA<^(V$/TK&MKIIR38IYW7;*1-8:7)?70C6XEEN=B(R'BA3;-&7J MY98GX&-'-0#K6,!G(B,ZLRUPI^%1"G!R/YQ!4)80&NVQKPS-5V=(B]WW0;6%14:$6%EG#!";@[&6UAO3699/ML,ZOV[1[N(A/-T^*/ M.H9[R,MZ2)/2'XJ<1?RF!3E;<9SI^&XR&MZ3+R7A.%K,O\P69/(P0FI<5S4L4?@B3 M&I<3^S%AZSIZ>/R*)05'>'0J'ITFTS4")HHEL,HQ?R:?^4L=(QS)\SR?7O6N MNAV$5K>BU47!JK1;O.2UBX>'7YU_1DCT*A*]9B1"KH2,R3B+"=1S+1\IT'M-/I(WSZ%9]^$SZ3+)(JEVK? M)N8:)HN,Y!9R"U),QK4SAP-/[Q!VOF<;JM>$WX(]DTD,2RI6(MJ3/#U[#DCJ MG7M^W^]=4HSA41GRQA!V+0H7B16%7P\;Y>+N(0-KJGJ> U,/4R;?*X.,-_5Y&,"?A1F98 M_W6 ]+O]\Z#701E90?#Q;OY5":TY5+I,TVUVZ&Y%+2LK^O5SX#F9 MV>9/\4[]+V:3HM@",R=!'-9)\,@%.'HSC[;*%)]/EV0A=%);? X0,\)R6R"C M[V!>Q%2 XC+39,\3,B5V3*8U'6F *SJ[3@!5DHL%YG9I-Q M@0W*2@3%>_I"L=@DY_PE71!&EE9!Y3QLK!IZ7H] M[(F$%9Z@D?MXCSMR(-]AY1Y8_0D:F8\WV2,'I+%'L.WSNIB]#*P !?_!;YRP M1P[(M]NCX.@AU-O<1Q-[Y(!L8H\"*SG!VPR(RQXYX!K9H\#*3_ V#]+('CDP M47L46/D).0!P>Q18W0CP=M_,'CE &MBCP(I# MT$@W-"TCY[[FW&PO9KEMWDOSAR+DC MO9*ZW="C<\W[)&D/1ZY8^\XT7'ND,E8QYU5;)VUC.2M;<%(R6=[<9(EB0M-B MK3MUIUQ+#J;3;D-O:%*L*Z//EI0&@U_*%">/3&[HEDFQMV)8RY20IV!>@N%@ MI+'$>2I\0Q=@:9\"O @:L!SC**&-!6,2,H3O_;C\&3!IK5>%E#/!)0V&8MTP MY[C5=UX9%@_&%Q 9Y=VI\0QKRTZ+Y2T].PP_/LG>V)+;.'36 M-/+T08I:*Q[V_LL)BS6;_,C16/'DL\&D'+R!6TH>N77B<&GY85FSX[V;IJFO M<,[+?Y#SGZUSS36W3%Z2]J/_-U?Y+8R3\?1<'-&K SI;"5R$&_H5[E=YYD#V MG9!.Z%$[BK+D^L4Y]>$=V_L+_"J^7U_RBG72[69P0\_R%UZ*3N7SJGNHR[CJ M+'^&^VB1S;>PSR5TR7M>;D?5UOM!)%[P6<<'')XC=\,31S"?@,41P+ \& /, M)WAA>?ZG_:S0_00,X[:*(BO49X7Z!*\8LAT^6)ZX3^Z?^$[S/$VS#*OH=AME ML,7JEF7P%X^&<0,/+ ]D>ENM\6[C$_+Z'& ]?6U"L)WBDXCM%*\U(/&Z@4>> MQ[N-Y0$/K O8[$#^>!Z8J;A/FD)7,6[8"<:1/,<0F,7XC&894IT,/O'^8* \^>Q\ETWLJ.?]74_P$4$L#!!0 ( M .2+JEB7BKL

-8?20$3;8T.P6BP^0"X99K>]9!:G%C:^?VZH:TE[VE-S9 MNMQ=%A?BTX'HE'QY%V)N:I%FGJ:QJ,';>$<-!)U4Q-Z*0CZFL6&P9:P!Q+MT MFF6SU%L,9KD8M;:X1+_)UW,#ECQ ,ZE._<]'<')O$8T.,5 MRMQD)HDU75Z(\4I!K-L53,[E9C(,]L""Q1]ZUYG\M(?8,V(/'U:-Y&:6J6"% M'*7?Z/6M>CR#+@^H%7I")\!K*_#,U#88CIV,IDAO8O0]C.=0XIS_4R-5%1:P MIJ+U$&3HD<%U!D.LL8DF"=9#;E9T!DZV]@A=*'UE4PX!19W=U,5SU %ORL'C M:*R$"@.4;ZH5E=>2BBTGW='K3.\?)H]:1NO<2KGW\$JV''..?[3\ 5!+ P04 M " #DBZI8)!Z;HJT #X 0 &@ 'AL+U]R96QS+W=O[IFBG#S^0W1UW6E\./VR./ /,+Q=Z*E%9"E*%1KD3,)HMC;! M4N++3):BJ#(9BBJ6<%H@XLD@;6E6?;!/3K3G>1,)KM\,<'AT_@%0 M2P,$% @ Y(NJ6&60>9(9 0 SP, !, !;0V]N=&5N=%]4>7!E&ULK9--3L,P$(6O$F5;)2XL6*"F&V +77 !8T\:J_Z39UK2VS-.VDJ@$A6% M3:QXWKS/GI>LWH\1L.B=]=B4'5%\% )5!TYB'2)XKK0A.4G\FK8B2K636Q#W MR^6#4,$3>*HH>Y3KU3.T.EY&TWP39G 8ED\C<+,:DH9HS5*$M?%P>L? ME.I$J+EST&!G(BY84(JKA%SY'7#J>SM 2D9#L9&)7J5CE>BM0#I:P'K:XLH9 M0]L:!3JHO>.6&F,"J;$#(&?KT70Q32:>,(S/N]G\P68*R,I-"A$YL01_QYTC MR=U59"-(9*:O>"&R]>S[04Y;@[Z1S>/]#&DWY(%B6.;/^'O&%_\;SO$1PNZ_ M/[&\UDX:?^:+X3]>?P%02P$"% ,4 " #DBZI8!T%-8H$ "Q $ M @ $ 9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0 ( .2+ MJE@P-C;F[@ "L" 1 " :\ !D;V-0&UL4$L! A0#% @ Y(NJ6)"]]OR+ M!0 *!H !@ ("!#0@ 'AL+W=O7!E&UL4$L%!@ ) D /@( "85 $! end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.1.u2 html 2 23 1 false 1 0 false 0 false false R1.htm 1001 - Document - Cover Page Sheet http://www.medicalpropertiestrust.com/role/CoverPage Cover Page Cover 1 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 3 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityAddressStateOrProvince, dei:EntityRegistrantName - d803751d8k.htm 7 d803751d8k.htm mpw-20240506.xsd mpw-20240506_cal.xml mpw-20240506_def.xml mpw-20240506_lab.xml mpw-20240506_pre.xml http://xbrl.sec.gov/dei/2023 true true JSON 16 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "d803751d8k.htm": { "nsprefix": "mpw", "nsuri": "http://www.medicalpropertiestrust.com/20240506", "dts": { "inline": { "local": [ "d803751d8k.htm" ] }, "schema": { "local": [ "mpw-20240506.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/currency/2023/currency-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/exch/2023/exch-2023.xsd", "https://xbrl.sec.gov/naics/2023/naics-2023.xsd", "https://xbrl.sec.gov/sic/2023/sic-2023.xsd", "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" ] }, "calculationLink": { "local": [ "mpw-20240506_cal.xml" ] }, "definitionLink": { "local": [ "mpw-20240506_def.xml" ] }, "labelLink": { "local": [ "mpw-20240506_lab.xml" ] }, "presentationLink": { "local": [ "mpw-20240506_pre.xml" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 1, "axisCustom": 0, "memberStandard": 0, "memberCustom": 1, "hidden": { "total": 6, "http://xbrl.sec.gov/dei/2023": 6 }, "contextCount": 2, "entityCount": 1, "segmentCount": 1, "elementCount": 29, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 35 }, "report": { "R1": { "role": "http://www.medicalpropertiestrust.com/role/CoverPage", "longName": "1001 - Document - Cover Page", "shortName": "Cover Page", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "P05_06_2024To05_06_2024", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d803751d8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P05_06_2024To05_06_2024", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d803751d8k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "terseLabel": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "City Area Code", "terseLabel": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "srt_ConsolidatedEntitiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidatedEntitiesAxis", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Axis]" } } }, "auth_ref": [] }, "srt_ConsolidatedEntitiesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidatedEntitiesDomain", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Domain]" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationLineItems", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Document Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_DocumentInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationTable", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Document Information [Table]", "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "terseLabel": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Document Type", "terseLabel": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "terseLabel": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation State Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "terseLabel": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "mpw_MptOperatingPartnershipLpMember": { "xbrltype": "domainItemType", "nsuri": "http://www.medicalpropertiestrust.com/20240506", "localname": "MptOperatingPartnershipLpMember", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "MPT Operating Partnership LP [Member]", "documentation": "MPT Operating Partnership LP." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre Commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "terseLabel": "Pre Commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "terseLabel": "Security 12b Title", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "terseLabel": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "terseLabel": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "terseLabel": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Written Communications", "terseLabel": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 17 0001193125-24-136307-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-24-136307-xbrl.zip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d803751d8k_htm.xml IDEA: XBRL DOCUMENT 0001287865 2024-05-06 2024-05-06 0001287865 mpw:MptOperatingPartnershipLpMember 2024-05-06 2024-05-06 MEDICAL PROPERTIES TRUST INC false 0001287865 0001524607 AL AL 8-K 2024-05-06 MPT OPERATING PARTNERSHIP, L.P. 001-32559 MD 20-0191742 DE 20-0242069 1000 Urban Center Drive 1000 Urban Center Drive Suite 501 Suite 501 Birmingham Birmingham 35242 35242 205 205 969-3755 969-3755 false false false false Common Stock, par value $0.001 per share, of Medical Properties Trust, Inc. MPW NYSE false false